Version 1 of 1 (2001-02-26 to 2002-03-01) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
BIOCHEM PHARMA
275, BOUL. ARMAND FRAPPIER LAVAL, QC H7V 4A7 Canada |
Telephone number: | 418-577-7129 |
Fax number: | 450-978-7755 |
Responsible officer name and position during the period of this registration: | ANDY SHELDON, DIRECTEUR SENIOR DES OPÉ`RATIONS COMMERCIALES |
Description of activities: | ENTREPRISE BIOPHARMACEUTIQUE |
Parent: | The corporation is not a subsidiary of any other parent corporations. |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: |
BIOCHEM VACCINS
|
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada |
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Telephone calls, Written communications, whether in hard copy or electronic format |
Subject Matter: Areas of Concern: | Health, Science and Technology |
Subject Matter: Particulars: | PARTENARIAT TECHNOLOGIQUE CANADA |